Biosynthesis and turnover of 1-deoxy-sphingoid bases (Homo sapiens)
From WikiPathways
Description
1-deoxy-ceramides
Quality Tags
Ontology Terms
Bibliography
View all... |
- Michaels S, Wang MZ; ''The revised human liver cytochrome P450 "Pie": absolute protein quantification of CYP4F and CYP3A enzymes using targeted quantitative proteomics.''; Drug Metab Dispos, 2014 PubMed Europe PMC Scholia
- Duan J, Merrill AH Jr; ''1-Deoxysphingolipids Encountered Exogenously and Made de Novo: Dangerous Mysteries inside an Enigma.''; J Biol Chem, 2015 PubMed Europe PMC Scholia
- Karsai G, Steiner R, Kaech A, Lone MA, von Eckardstein A, Hornemann T; ''Metabolism of HSAN1- and T2DM-associated 1-deoxy-sphingolipids inhibits the migration of fibroblasts.''; J Lipid Res, 2021 PubMed Europe PMC Scholia
- Carreira AC, Santos TC, Lone MA, Zupanaciac E, Lloyd-Evans E, de Almeida RFM, Hornemann T, Silva LC; ''Mammalian sphingoid bases: Biophysical, physiological and pathological properties.''; Prog Lipid Res, 2019 PubMed Europe PMC Scholia
- Schwartz NU, Mileva I, Gurevich M, Snider J, Hannun YA, Obeid LM; ''Quantifying 1-deoxydihydroceramides and 1-deoxyceramides in mouse nervous system tissue.''; Prostaglandins Other Lipid Mediat, 2019 PubMed Europe PMC Scholia
- Simpson AE; ''The cytochrome P450 4 (CYP4) family.''; Gen Pharmacol, 1997 PubMed Europe PMC Scholia
- Lone MA, Santos T, Alecu I, Silva LC, Hornemann T; ''1-Deoxysphingolipids.''; Biochim Biophys Acta Mol Cell Biol Lipids, 2019 PubMed Europe PMC Scholia
History
View all... |
External references
DataNodes
View all... |
Annotated Interactions
No annotated interactions